Target intelligence / Profile preview

Neisseria meningitidis Capsular Polysaccharide Serogroup A (CPS Serogroup A)

Target
CPS Serogroup A
Molecular classification
Polysaccharide, Capsular Polysaccharide, Bacterial Antigen
01

Overview

Neisseria meningitidis serogroup A capsular polysaccharide is a polymer of N-acetyl-mannosamine-1-phosphate and a major virulence factor responsible for the bacterium's ability to cause invasive meningococcal disease. It enables the organism to evade the host's immune system. It is also a primary target for vaccine development. Vaccines against this polysaccharide induce protective immunity by generating antibodies that promote bacterial killing.

Other names
N. meningitidis serogroup A capsuleGroup A meningococcal polysaccharideSerogroup A CPSN-acetyl-mannosamine-1-phosphate polymer (N. meningitidis)
02

Mechanism of action

Vaccines induce antibodies against the capsular polysaccharide, leading to opsonization, complement activation, and killing of the bacteria. Conjugate vaccines elicit a T-cell dependent immune response, resulting in longer-lasting immunity, especially in infants.

03

Biological functions

Immune evasionVirulence factorCapsule formationAdhesionComplement resistancePhagocytosis inhibition
04

Disease associations

InfectionMeningitisMeningococcal diseaseEpidemic meningitis
05

Safety considerations

Vaccine-related adverse events (rare)Hyporesponsiveness to vaccination in certain populationsPotential for serogroup replacement following widespread vaccination
06

Interacting drugs

Conjugate vaccines (e.g., MenAfriVac)

1 more in the full profile.

07

Biomarkers

Anti-capsular polysaccharide antibody titers (IgG)Serum bactericidal antibody (SBA) titersOpsonophagocytic activity (OPA)

Beyond the preview

Go deeper on Neisseria meningitidis Capsular Polysaccharide Serogroup A (CPS Serogroup A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neisseria meningitidis Capsular Polysaccharide Serogroup A (CPS Serogroup A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call